Latest News
Key Due Diligence Steps for Evaluating 1031 Exchange Opportunities
For real estate investors, the 1031 exchange is an excellent way to preserve wealth. That said, the 45-day identification deadline imposed by the IRS often makes investors rush. They may end up skipping due diligence and closing acquisitions as quickly as possible. This rushed approach creates unnecessary risks, and properties often become poor investments. If [...]
Via Visibility · February 24, 2026
Oddity's valuation is getting crushed following the company's latest earnings report.
Via The Motley Fool · February 25, 2026
Is the stock ready for another breakout?
Via The Motley Fool · February 25, 2026
Let's dive into the bull and bear thesis for a company like Telus (TSX:T) and where this stock may be headed over the medium to long term.
Via The Motley Fool · February 25, 2026
Let's dive into the age-old question of whether buying into a stock market at all time highs makes sense, or if investors should be more cautious.
Via The Motley Fool · February 25, 2026

Structure Therapeutics develops oral drugs for chronic diseases, with lead assets targeting diabetes, obesity, and cardiovascular care.
Via The Motley Fool · February 25, 2026
The new 15% "global" tariff replaces the discontinued "Liberation Day" tariffs.
Via The Motley Fool · February 25, 2026
Shares of financial services company Robinhood (NASDAQ:HOOD)
jumped 5.9% in the afternoon session after a rally in Bitcoin renewed expectations for increased trading activity on its platform.
Via StockStory · February 25, 2026
Shares of bitcoin development company Strategy (NASDAQ:MSTR) jumped 9% in the afternoon session after a rally in the price of Bitcoin created upward pressure on the heavily shorted stock.
Via StockStory · February 25, 2026
Shares of boat and marine products retailer MarineMax (NYSE:HZO)
jumped 8.8% in the afternoon session after reports surfaced that more potential buyers, including private equity firms Blackstone and Centerbridge Partners, expressed interest in acquiring the company.
Via StockStory · February 25, 2026
Shares of biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ)
jumped 13.5% in the afternoon session after the company reported better-than-expected fourth-quarter 2025 revenue and earnings.
Via StockStory · February 25, 2026
Shares of global payments company Flywire (NASDAQ:FLYW) jumped 10.1% in the afternoon session after it reported fourth-quarter 2025 results that beat Wall Street's expectations for both revenue and earnings. Revenue grew 39.7% year-over-year to $157.5 million, surpassing analyst estimates by 9.3%. The company also posted a GAAP earnings per share of $0.00, which was an upside surprise to analysts who had forecast a loss of $0.01 per share. In addition, adjusted EBITDA of $25.4 million came in nearly 10% ahead of consensus. Overall, the significant top- and bottom-line beats drove the positive investor sentiment.
Via StockStory · February 25, 2026
Shares of server solutions provider Super Micro (NASDAQ:SMCI) jumped 8% in the afternoon session after the company made two significant announcements: a successful test of its AI infrastructure as a high-speed 'Virtual Power Plant' and the launch of a new enterprise AI data platform.
Via StockStory · February 25, 2026
Shares of data storage solutions provider Pure Storage (NYSE:PSTG) jumped 9.6% in the afternoon session after the company announced a major rebranding to 'Everpure' and its intent to acquire data intelligence firm 1touch, signaling a strategic shift ahead of its earnings report.
Via StockStory · February 25, 2026
Shares of healthcare solutions company Evolent Health (NYSE:EVH)
jumped 20.7% in the afternoon session after the company reported fourth-quarter earnings that beat expectations and provided an optimistic revenue forecast for the upcoming year.
Via StockStory · February 25, 2026
Shares of home automation and security solutions provider Resideo Technologies (NYSE:REZI)
jumped 13.5% in the afternoon session after the company reported fourth-quarter revenue that topped Wall Street estimates and provided an upbeat financial outlook for 2026. Resideo's sales in the fourth quarter rose 2% year-on-year to $1.90 billion, edging past analysts' expectations. However, the company's adjusted earnings of $0.50 per share fell short of consensus estimates by 4.5%. Investors appeared to focus on the company's strong forecast. For the upcoming first quarter, Resideo guided for revenue of $1.88 billion at the midpoint, which was 4.6% higher than what analysts had anticipated. Furthermore, its full-year 2026 guidance was a highlight, with projections for adjusted earnings per share and EBITDA beating consensus estimates by 11% and 5% respectively. The optimistic outlook suggests management expects robust performance ahead, outweighing the mixed results of the past quarter.
Via StockStory · February 25, 2026
The advent of artificial intelligence is about to be bottlenecked in a big way most investors have yet to notice.
Via The Motley Fool · February 25, 2026

This biotech innovator develops peptide-based therapies for blood and immune disorders, advancing a pipeline of clinical-stage candidates.
Via The Motley Fool · February 25, 2026
His latest SEC filing reveals that the venture capitalist's hedge fund sold its entire stock portfolio last quarter.
Via The Motley Fool · February 25, 2026
Valued at a market cap of $5.7 billion, EIF is a TSX dividend stock that remains a top pick in 2026.
Via The Motley Fool · February 25, 2026

BAMCO trimmed its position in Vail Resorts as Epic Pass sales set up the winter season. Vail runs a large portfolio of destination resorts, and investors will be watching whether traffic and guest spending will support the company's earnings outlook.
Via The Motley Fool · February 25, 2026

This U.S. telecom and technology provider reported a notable insider sale amid a year of significant share price movement.
Via The Motley Fool · February 25, 2026

Disc Medicine develops therapies for rare blood disorders, leveraging clinical-stage biotech expertise in red blood cell biology.
Via The Motley Fool · February 25, 2026
Don't rush to buy the dip on these popular quantum computing stocks.
Via The Motley Fool · February 25, 2026
This under-the-radar Canadian stock pays a monthly dividend and is quietly building a compelling growth story.
Via The Motley Fool · February 25, 2026
